At a glance
ClinicalIndex Comparison RecordN/ACompleted· 99 enrolled
Drug / intervention
Rapid SARS-CoV-2 Antigen Testdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Over the Counter Rapid Antigen Test for Detection of SARS-CoV-2 Virus: Human Usability Study
In Brief
A clinical study evaluating Rapid SARS-CoV-2 Antigen Test for Sars-CoV-2 Infection and COVID-19. Completed, enrolled 99 participants across 1 site.
Detailed Summary
SARS-CoV-2 rapid antigen over the counter usability study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSars-CoV-2 Infection, COVID-19
CountriesUnited States
CollaboratorsNew Day Diagnostics
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
Primary CompletionOct 2021
First PostedOct 2022
TodayJul 2026
First PostedOct 18, 2022
Enrollment StartOct 7, 2021
Primary CompletionOct 27, 2021
TodayJul 2, 2026
Enrollment to primary: 20 daysPosted 3.7 years ago
Interventions
Rapid SARS-CoV-2 Antigen Testdevice
Candidate Ag self-test kit anterior nasal specimen collection and testing will be done under the supervision of qualified site personnel in person.